ABT-869
Product Specifications
Background
ABT-869 (796967-16-3) ia a structurally novel, potent inhibitor of receptor tyrosine kinases inhibiting VEGFR and PDGFR and related kinases with IC50s= 3, 4, 4, 66, 3 and 14 nM for VEGFR1, VEGFR2, FLT3, PDGFRβ, CSF-1R and KIT respectively.1,2 Protects cells from necroptosis and rescues SIRS mice from TNF-α-induced shock and death.3 Exerts anti-obesity effects by promoting adipocyte browning.4 Inhibits angiogenesis.5
Conjugation
Unconjugated
Buffer
Off-white solid
Storage Conditions
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb1641053-01 50 µg
Hepatoma-derived growth factor-related protein 3
Sign In for Pricing
View Details orb1641053-02 100 µg
Hepatoma-derived growth factor-related protein 3
Sign In for Pricing
View Details orb1641053-03 1 mg
Hepatoma-derived growth factor-related protein 3
Sign In for Pricing
View Details 
A04090-1-Dylight488 100 µg
Anti-ACF1/BAZ1A Antibody Picoband® (Dylight488 Conjugate)
Sign In for Pricing
View Details K7212702 1.0 µg DNA
Olr106 sgRNA CRISPR Lentivector (Rat) (Target 1)
Sign In for Pricing
View Details 